CD8+ cytotoxic T cells (CTLs) can efficiently recognize and destroy tumor cells which expose peptides derived from intracellular tumor-associated antigens (TAAs) in complex with human leukocyte antigen (HLA) class I molecules on the surface [9]. Here, CD8A is linked to neoplasm.